CRMD - CIK 0001410098
The table below shows CorMedix Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $311.71M | $43.47M | - | $65.41K | $190.94K | $239.23K |
| Cost of revenue | $22.09M | $3.03M | - | $3.73K | $148.94K | $204.85K |
| Gross profit | $275.75M | $40.28M | - | $61.67K | $42.00K | $34.38K |
| R&D | $19.33M | $3.94M | $13.16M | $10.68M | $13.13M | $13.38M |
| SG&A |
CorMedix Inc. reported annual revenue of $311.71M for fiscal year 2025. That is up 617.0% from $43.47M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $210.13K (FY 2015) to $311.71M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $68.22M |
| $29.96M |
| $35.80M |
| $20.01M |
| $16.35M |
| $13.88M |
| Operating income | $150.14M | -$22.36M | -$48.96M | -$30.62M | -$29.44M | -$27.22M |
| Income tax | -$13.04M | -$1.40M | - | -$585.62K | -$1.25M | -$5.17M |
| Net income | $163.06M | -$17.93M | -$46.34M | -$29.70M | -$28.21M | -$22.03M |
| EPS (diluted) | $2.04 | -$0.30 | -$0.91 | -$0.74 | -$0.75 | - |